|
|
| | Epsiprantel Basic information |
| Product Name: | Epsiprantel | | Synonyms: | 2-(cyclohexanecarbonyl)-1,2,3,7,8,12b-hexahydrobenzo[c]pyrazino[1,2-a]azepin-4(6H)-one;2-(cyclohexanecarbonyl)-1,3,6,7,8,12b-hexahydropyrazino[2,1-a][2]benzazepin-4-one;Epsiprantel;Pyrazino2,1-a2benzazepin-4(1H)-one, 2-(cyclohexylcarbonyl)-2,3,6,7,8,12b-hexahydro-;4-cyclohexanecarbonyl-4,7-diazatricyclo[9.4.0.0,2,7]pentadeca-1(15),11,13-trien-6-one | | CAS: | 98123-83-2 | | MF: | C20H26N2O2 | | MW: | 326.437 | | EINECS: | | | Product Categories: | | | Mol File: | 98123-83-2.mol |  |
| | Epsiprantel Chemical Properties |
| Melting point | 189-190° | | Boiling point | 553.7±50.0 °C(Predicted) | | density | 1.20±0.1 g/cm3(Predicted) | | pka | -0.97±0.20(Predicted) |
| | Epsiprantel Usage And Synthesis |
| Uses | Epsiprantel (BRL-38705) is a compound with anti-Echinococcus activity that can cause the death of protoscolex, larvae and adults in vitro, and is more effective against mature worms than larvae in vivo, with no side effects. | | Veterinary Drugs and Treatments | Epsiprantel is indicated for the treatment (removal) of Dipylidium
caninum and Taenia pisiformis in dogs, and Dipylidium caninum
and Taenia taeniaeformis in cats. | | References | [1] In vitro and in vivo efficacy of epsiprantel against Echinococcus granulosus DOI:10.1016/0034-5288(91)90087-5 |
| | Epsiprantel Preparation Products And Raw materials |
|